Genetic Technologies
GENE
$2.28
Share price
0.88%
Change (1 day)
132.65%
Change (1 year)
Categories
Genetic Technologies (GENE) Fails to deliver data
Key failure to deliver metrics for Genetic Technologies:
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: $0.09 M
Failures to deliver for Genetic Technologies (GENE) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Genetic Technologies (GENE) - since 2019
Volume in USD (price x number of shares), data since 2019Genetic Technologies (GENE) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $1.62 M | 343.83% |
| 2022 | $0.36 M | -96.55% |
| 2021 | $10.6 M | -41.25% |
| 2020 | $18.04 M | 8647.48% |
| 2019 | $0.2 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $0.10 B | $0.34 B | 🇺🇸 USA |
 Quest Diagnostics
DGX | $4.64 M | $43.46 M | 🇺🇸 USA |
 Danaher DHR | $42.73 M | $0.15 B | 🇺🇸 USA |
 LabCorp LH | $0.1 M | $48.7 M | 🇺🇸 USA |
 Compugen CGEN | $0.61 M | $2.28 M | 🇮🇱 Israel |
 Neogen NEOG | $6.24 M | $15.96 M | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.19 M | $1.19 M | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $0.02 M | $0.24 M | 🇺🇸 USA |